Study on the relationship between LOH and MI of FHIT gene and the development of cervical carcinoma

Journal of Sichuan University (Medical Science)

Volumn 36, Issue 4, 2005, Pages 506-509

  Liu, Hui ^a   Peng, Zhi Lan ^a   Wang, He ^a   Liu, Shan Ling ^a   Zhang, Chong Shu ^a   Tang, Qian Ping ^a   He, Bin ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Cervical carcinoma; CINs; FHIT; LOH; MI

Indexed keywords

FRAGILE HISTIDINE TRIAD PROTEIN;

ARTICLE; CANCER INVASION; CANCER SCREENING; EARLY DIAGNOSIS; FEMALE; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MICROSATELLITE INSTABILITY; PROGNOSIS; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU;

EID: 23244438492     PISSN: 1672173X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Ohta M, Inoue H, Cotticelli MG, et al. The FHIT gene, spanning the chromosome 3p 14.2 fragile site and renal carcinoma-associated t (3; 8) breakpoint, is abnormal in digestive tract cancer. Cell, 1996;84(4):587.
2. Druck T, Berk L, Huebner K. FHITness and cancer. Oncol Res, 1998;10(7):341.
3. Kiyoshi Y, Takayuki E, Takafumi N, et al. FHIT alterations in cancerous and non-cancerous cervical epithelium. Int J Cancer, 2000;85:6.
4. Tomlinson I, Bodmer W. Selection, the mutation rate and cancer: ensuring that the tail does not wag the dog. Nat Med, 1999;5(1):11.
5. Sia EA, Jinks-Robertson S, Petes TD. Genetic control of microsatellite stability. Mutat Res, 1997;383(1):61.
6. Kiyoshi Y, Takayuki E, Takafumi N, et al. FHIT alterations in cancerous and non-cancerous cervical epithelium. Int J Cancer, 2000;85:6.
7. Guo Z, Wu F, Asplund A, et al. Analysis of intratumoral heterogeneity of chromosome 3p deletions and genetic evidence of polyclonal origin of cervical squamous carcinoma. Mod Pathol, 2001;14(2):54.
8. Kersemaekers AM, Hermans J, Fleuren GJ, et al. Loss of heterozygosity for defined regions on chromosomes 3, 11 and 17 in carcinomas of the uterine cervix. Br J Cancer, 1998;77 (2):192.
9. Kersemaekers AM, Kenter GG, Hermans J, et al. Allelic loss and prognosis in carcinoma of the uterine cervix. Int J Cancer, 1998;79(4):411.
10. Birrer MJ, Hendricks D, Farley J, et al. Abnormal Fhit expression in malignant and premalignant lesions of the cervix. Cancer Res, 1999;59(20):5270.
11. Wistuba II, Montellano FD, Milchgrub S, et al. Deletions of chromosome 3p are frequent and early events in the pathogenesis of uterine cervical carcinoma. Cancer Res, 1997; 57(15):3154.
12. Liu FS, Hsieh YT, Chen JT, et al. FHIT (fragile histidine triad) gene analysis in cervical intraepithelial neoplasia. Gynecol Oncol, 2001;82(2):283.
13. Twai T, Yokota S, Nakao M, et al. Frequent aberration of FHIT gene expression in acute leukemias. Cancer Res, 1998;58 (22):5182.